- 101. Pharyngeal Cancer Stage I
- [Stage 1 includes T1, N0, M0. T1: Tumor confined to the nasopharynx. ( NCI )] (UMLS (NCI) C0854998) Stage I Pharyngeal Cancer;
=Neoplastic Process | - 151. phenotype
- [the entire physical, biochemical, and physiological makeup of an individual as determined both genetically and environmentally; also, any one or any group of such traits. ( CSP )] (UMLS (CSP) C0031437) =Organism Attribute =Genetics;
=autosomal dominant trait;
autosomal recessive trait;
sex chromosome linked trait |
- 102. Pharyngeal Cancer Stage II
- [Stage 2 includes T2a,T2b,N0,M0/T1,T2,T2a,T2b,N1,M0. T2: Tumor extends to soft tissues of oropharynx and/or nasal fossa. T2a: without parapharyngeal extension. T2b: with parapharyngeal extension. N1: Unilateral metastasis in lymph node(s), 6 cm or less in greatest dimension, above the supraclavicular fossa. ( NCI )] (UMLS (NCI) C1378108) Stage II Carcinoma of Pharynx;
Stage II Carcinoma of the Pharynx;
Stage II Pharyngeal Cancer;
Stage II Pharyngeal Carcinoma;
Stage II Pharynx Carcinoma =Neoplastic Process | - 152. phenoxyacetate
- [ ] (UMLS (CSP) C0031440) =Organic Chemical =glycolate;
=[2,3-Dichloro-4-(2-methylene-1-oxobutyl)phenoxy]acetic Acid |
- 103. Pharyngeal Cancer Stage III
- [Stage 3 includes T1,T2a,T2b,N2,M0/T3,N0,N1,N2,M0. T3: Tumor invades bony structures and/or paranasal sinuses. N2: Bilateral metastasis in lymph node(s), 6 cm or less in greatest dimension, above the supraclavicular fossa. ( NCI )] (UMLS (NCI) C1378109) Stage III Carcinoma of Pharynx;
Stage III Carcinoma of the Pharynx;
Stage III Pharyngeal Cancer;
Stage III Pharyngeal Carcinoma;
Stage III Pharynx Carcinoma =Neoplastic Process | - 153. PHENPROCOUMON
- [Coumarin derivative that acts as a long acting oral anticoagulant. ( MSH )] (UMLS (NCI) C0031444) =Organic Chemical; Pharmacologic Substance ;
=4-Hydroxycoumarins;
[BL100] ANTICOAGULANTS =PHENPROCOUMON 3 MG |
- 104. Pharyngeal Cancer Stage IVA
- (UMLS (NCI) C1336359) Stage IVA Carcinoma of Pharynx;
Stage IVA Carcinoma of the Pharynx;
Stage IVA Pharyngeal Cancer;
Stage IVA Pharyngeal Carcinoma;
Stage IVA Pharynx Carcinoma =Neoplastic Process | - 154. PHENSUXIMIDE
- (UMLS (NCI) C0070592) =Organic Chemical; Pharmacologic Substance ;
=[CN400] ANTICONVULSANTS;
succinimide |
- 105. Pharyngeal Cancer Stage IVB
- (UMLS (NCI) C1336390) Stage IVB Carcinoma of Pharynx;
Stage IVB Carcinoma of the Pharynx;
Stage IVB Pharyngeal Cancer;
Stage IVB Pharyngeal Carcinoma;
Stage IVB Pharynx Carcinoma =Neoplastic Process | - 155. phentermine
- [central nervous system stimulant and sympathomimetic with actions and uses similar to dextroamphetamine; used in the treatment of obesity. ( CSP )] (UMLS (CSP) C0031447) =Organic Chemical; Pharmacologic Substance ;
=Amfetamine;
[CN801] AMPHETAMINES;
[GA750] APPETITE SUPPRESSANTS;
[GA751] CENTRALLY-ACTING APPETITE SUPPRESSANTS =MEPHENTERMINE;
Phentermine HCl;
PHENTERMINE RESIN COMPLEX;
Phentermine HCl;
PHENTERMINE RESIN COMPLEX |
- 106. Pharyngeal Cancer Stage IVC
- (UMLS (NCI) C1336409) Stage IVC Carcinoma of Pharynx;
Stage IVC Carcinoma of the Pharynx;
Stage IVC Pharyngeal Cancer;
Stage IVC Pharyngeal Carcinoma;
Stage IVC Pharynx Carcinoma =Neoplastic Process | - 156. Phentermine HCl
- [The hydrochloride salt form of phentermine, a sympathomimetic amine with central nervous system (CNS) stimulant and appetite depressant properties. Phentermine hydrochloride stimulates the release of norepinephrine and dopamine from nerve endings and blocks the reuptake of these monoamines at the neuronal junctions, resulting in CNS stimulation and metabolic effects, including appetite-suppression, decreased gastric acid secretion and increased blood pressure. ( NCI )] (UMLS (NCI) C0282304) =Organic Chemical; Pharmacologic Substance =phentermine;
=PHENTERMINE HYDROCHLORIDE 15 MG;
PHENTERMINE HYDROCHLORIDE 37.5 MG;
PHENTERMINE HYDROCHLORIDE 30 MG;
PHENTERMINE HYDROCHLORIDE 18.75 MG;
PHENTERMINE HYDROCHLORIDE 8 MG |
- 107. Pharyngeal Cancer, Recurrent
- (UMLS (NCI) C0854996) Recurrent Cancer of Pharynx;
Recurrent Cancer of the Pharynx;
Recurrent Carcinoma of Pharynx;
Recurrent Carcinoma of the Pharynx;
Recurrent Pharyngeal Cancer;
Recurrent Pharyngeal Carcinoma;
Recurrent Pharynx Cancer;
Recurrent Pharynx Carcinoma;
Relapsed Cancer of Pharynx;
Relapsed Cancer of the Pharynx;
Relapsed Carcinoma of Pharynx;
Relapsed Carcinoma of the Pharynx;
Relapsed Pharyngeal Cancer;
Relapsed Pharyngeal Carcinoma;
Relapsed Pharynx Cancer;
Relapsed Pharynx Carcinoma =Neoplastic Process | - 157. phenylacetate
- [ ] (UMLS (CSP) C0031452) =Organic Chemical =Acids, Carbocyclic;
phenylcarboxylate =3,4 dihydroxyphenylacetate;
homovanillate;
chlorophenoxyacetate;
CYCLOPENTOLATE;
2-[(2,6-Dichlorophenyl)amino]benzeneacetic Acid;
Diphenylacetic Acids;
alpha-Phenyl-2-piperidineacetic Acid Methyl Ester;
phenylacetic acid;
GUANFACINE |
- 108. PHARYNGEAL DIVERTICULEC
- [ ] (UMLS (ICD9CM) C0396338) =Therapeutic or Preventive Procedure
| - 158. phenylalaninase
- [An enzyme of the oxidoreductase class that catalyzes the formation of L-TYROSINE, dihydrobiopterin, and water from L-PHENYLALANINE, tetrahydrobiopterin, and oxygen. Deficiency of this enzyme may cause PHENYLKETONURIAS and PHENYLKETONURIA, MATERNAL. EC 1.14.16.1. ( MSH )] (UMLS (CSP) C0031456) =Amino Acid, Peptide, or Protein; Enzyme ;
=Oxygenase;
|
- 109. Pharyngeal Groove
- (UMLS (NCI) C1280559) =Embryonic Structure
| - 159. phenylalanine
- [essential aromatic amino acid that is a precursor of melanin, dopamine, norepinephrine and thyroxine. ( CSP )] (UMLS (CSP) C0031453) =Amino Acid, Peptide, or Protein; Pharmacologic Substance; Biologically Active Substance =Amino Acids, Cyclic;
Amino Acids, Essential;
primary aminoacid;
Inactive Ingredient Preparations =dihydroxyphenylalanine;
4-[bis(2-chloroethyl)amino]-L-phenylalanine;
A 4166;
VIVONEX T.E.N. POWDER,PKT,80.4GM;
PHENYLALANINE 500 MG;
PHENYLALANINE 0.32 GM;
PHENYLALANINE 0.48 GM;
PHENYLALANINE 1.04 MG/ML;
PHENYLALANINE 1.26 MG/ML;
PHENYLALANINE 1.49 MG/ML;
PHENYLALANINE 10.4 MG/ML;
PHENYLALANINE 100 MG/100ML;
PHENYLALANINE 154 MG/100ML;
PHENYLALANINE 155 MG/100ML;
PHENYLALANINE 17 MG;
PHENYLALANINE 170 MG;
PHENYLALANINE 2.09 MG/ML;
PHENYLALANINE 2.28 MG/ML;
PHENYLALANINE 2.53 MG/ML;
PHENYLALANINE 2.98 MG/ML;
PHENYLALANINE 217 MG;
PHENYLALANINE 22.25 MG;
PHENYLALANINE 220 MG/100ML;
PHENYLALANINE 290 MG/100ML;
PHENYLALANINE 3.1 MG/ML;
PHENYLALANINE 3.8 MG/ML;
PHENYLALANINE 30 MG/5ML;
PHENYLALANINE 300 MG/100ML;
PHENYLALANINE 310 MG;
PHENYLALANINE 340 MG;
PHENYLALANINE 340 MG/100ML;
PHENYLALANINE 36 MG/GM;
PHENYLALANINE 380 MG;
PHENYLALANINE 4.27 MG/ML;
PHENYLALANINE 4.8 MG;
PHENYLALANINE 440 MG/100ML;
PHENYLALANINE 447 MG/100ML;
PHENYLALANINE 480 MG/100ML;
PHENYLALANINE 490 MG;
PHENYLALANINE 526 MG;
PHENYLALANINE 526 MG/100ML;
PHENYLALANINE 560 MG;
PHENYLALANINE 560 MG/100ML;
PHENYLALANINE 7.9 MG/ML;
PHENYLALANINE 726 MG/100ML;
PHENYLALANINE 825 MG;
PHENYLALANINE 880 MG |
- 110. Pharyngeal Muscle
- [The muscles of the pharynx, the inferior, middle and superior constrictors, salpingopharyngeus, and stylopharyngeus. (MeSH) ( NCI )] (UMLS (NCI) C0031346) =Body Part, Organ, or Organ Component ;
| - 160. phenylalanine analog
- [synthetic or natural compound which resembles phenylalanine in structure and/or function. ( CSP )] (UMLS (CSP) C0597209) =Amino Acid, Peptide, or Protein ;
=aminoacid analog;
=fenclonine |
- 111. Pharyngeal Pouch
- (UMLS (NCI) C0231067) =Embryonic Structure
| - 161. phenylalanine free
- [Phenylketonuria diet. ( HL7V3.0 )] (UMLS (HL7) C1550574) =Intellectual Product =Diet;
|
- 112. pharyngitis
- [inflammation of the throat. ( CSP )] (UMLS (CSP) C0031350) =Disease or Syndrome ;
=DISEASE OF PHARYNX NOS;
respiratory infection;
oral pharyngeal disorder;
| - 162. Phenylalanine Metabolism
- [The chemical reactions and pathways involving L-phenylalanine, the levorotatory isomer of 2-amino-3-phenylpropanoic acid. [GOC:go_curators] ( GO )] (UMLS (NCI) C1327004) Phenylalanine Metabolism Pathway;
=Molecular Function |
- 113. PHARYNGOCONJUNCT FEVER
- (UMLS (ICD9CM) C0031351) =Disease or Syndrome ;
| - 163. phenylalaninemia
- [group of autosomal recessive disorders marked by a deficiency of the hepatic enzyme phenylaline hydroxylase or less frequently by reduced activity of dihydropteridine reductase. ( CSP )] (UMLS (CSP) C0031485) =Disease or Syndrome ;
=Amino Acid Metabolism, Inborn Errors;
Arrieration mentale =Phenylketonuria, Maternal |
- 114. Pharyngoesophageal Diverticulum
- [A DIVERTICULUM at the upper end of the ESOPHAGUS through the cricopharyngeal muscle at the junction of the PHARYNX and the esophagus. ( MSH )] (UMLS (NCI) C0085232) =Disease or Syndrome =Diverticulum, Esophageal;
| - 164. phenylalkane
- [ ] (UMLS (CSP) C0597211) =Organic Chemical ;
|
- 115. PHARYNGOSCOPY
- [ ] (UMLS (ICD9CM) C0192232) =Diagnostic Procedure
| - 165. phenylalkanol
- [ ] (UMLS (CSP) C0597212) =Organic Chemical ;
|
- 116. PHARYNGOTOMY
- [ ] (UMLS (ICD9CM) C0192198) =Therapeutic or Preventive Procedure
| - 166. phenylalkoxyalkylamine
- [ ] (UMLS (CSP) C0597213) =Organic Chemical ;
=phenylalkylamine;
=atenolol;
DIPHENHYDRAMINE;
FLUOXETINE;
GALLAMINE TRIETHIODIDE;
|
- 117. pharynx
- [funnel-shaped fibromuscular tube that conducts food to the esophagus, and air to the larnyx and lungs. ( CSP )] (UMLS (NCI) C0031354) =Body Part, Organ, or Organ Component ;
=Body System, Gastrointestinal;
Body System, Pulmonary;
Body Part;
=Nasopharyngeal;
oral pharyngeal;
| - 167. phenylalkylamine
- [ ] (UMLS (CSP) C0597214) =Organic Chemical ;
=cyclic amine;
=benzylamine;
METHADONE;
Phenethylamines;
phenolic amine;
phenylalkoxyalkylamine |
- 118. Pharynx necrosis
- (UMLS (NCI) C1397204) Pharynx Necrosis Adverse Event =Finding
| - 168. phenylamide
- [ ] (UMLS (CSP) C0597215) =Amino Acid, Peptide, or Protein ;
=amide;
=4-Hydroxyacetanilide;
(E)-N-[(4-Hydroxy-3-methoxyphenyl)methyl]-8-methyl-6-nonenamide;
.omega.-Diethylamino-2,6-dimethylacetanilide;
PROCAINAMIDE;
cis-4-Amino-5-Chloro-N-(1-(3- (p-fluorophenoxy)propyl)-3-methoxy-4- piperidyl)-o-Anisamide;
p aminohippurate;
|
- 119. Phase
- [A distinguishable part, a stage in a series of events or in a process of development, e.g. any of the varying aspects or stages in course of a disease; a fraction of a cycle. ( NCI )] (UMLS (NCI) C0205390) =Temporal Concept
| - 169. PHENYLBUTAZONE
- [A butyl-diphenyl-pyrazolidinedione that has anti-inflammatory, antipyretic, and analgesic activities. It has been used in ANKYLOSING SPONDYLITIS; RHEUMATOID ARTHRITIS; and REACTIVE ARTHRITIS. ( MSH )] (UMLS (NCI) C0031463) =Organic Chemical; Pharmacologic Substance ;
=Pyrazole Compound;
[MS102] NONSALICYLATE NSAIS, ANTIRHEUMATIC;
TO BE DELETED INGREDIENT PREPARATIONS;
=OXYPHENBUTAZONE;
3,5-Pyrazolidinedione, 1,2-diphenyl-4-(2-(phenylsulfinyl)ethyl)-;
|
- 120. phase change
- [in physical chemistry, alteration of a physically or chemically distinct homogeneous and mechanically separable part of a system, for example the ice and steam phases of water. ( CSP )] (UMLS (CSP) C0597205) =Quantitative Concept ;
=Physical Phenomenon;
=crystallization;
Freeze Technique;
precipitation;
evaporation;
| - 170. phenylbutyrate
- [cytostatic, apoptosis inducing agent; effects cell differentiation. ( CSP )] (UMLS (CSP) C0031465) =Organic Chemical =Acids, Carbocyclic;
butyrate;
phenylcarboxylate;
=PHENYLBUTYRATE |
- 121. Phase of life problem adult
- (UMLS (ICPC) C0497324) (Phase of life problem adult; BIZITZAKO FASEKO ARAZOA:HELDUAK; Problem i en livsfase hos voksen; Levensfaseprobleem volwassene; AIKUISEN ELAMANVAIHEKRIISI; Probleme de phase de vie adulte; Lebensphasenbezog Probl Erwachsener; shalav shel beayot xaim bimvugar; felnott korosztalyi problema; Problema di fase di vita in adulto; LIVSFASEPROBLEM HOS VOKSNE; Prob numa fase da vida do adulto; Cambio estado/situacion adulto; LIVSKRIS HOS VUXEN) =Sign or Symptom =Symptoms and Complaints Component; PSYCHOLOGICAL
| - 171. phenylcarboxylate
- [ ] (UMLS (CSP) C0597216) =Organic Chemical ;
=cyclic acid;
=benzoate;
phenylacetate;
phenylbutyrate |
- 122. Phaseolus
- [A plant genus in the family FABACEAE which is the source of edible beans and the lectin PHYTOHEMAGGLUTININS. ( MSH )] (UMLS (CSP) C0031357) =Plant ;
| - 172. phenylenediamine
- [ ] (UMLS (CSP) C0031468) =Organic Chemical; Pharmacologic Substance ;
|
- 123. Phasianidae
- [ ] (UMLS (CSP) C0325635) =Bird
| - 173. PHENYLEPHRINE
- [direct acting sympathomimetic amine that stimulates alpha-adrenergic receptors and is a powerful vasoconstrictor. ( CSP )] (UMLS (NCI) C0031469) =Organic Chemical; Pharmacologic Substance ;
=adrenergic agent;
Ethanolamines;
[NT100] DECONGESTANTS, NASAL;
phenolic amine;
[AU100] SYMPATHOMIMETICS (ADRENERGICS);
[OP600] MYDRIATICS/CYCLOPLEGICS, TOPICAL OPHTHALMIC;
[RS201] HEMORRHOIDAL PREPARATIONS WITHOUT STEROID;
=PHENYLEPHRINE HYDROCHLORIDE;
Phenylephrine Bitartrate;
PHENYLEPHRINE TANNATE;
PHENYLEPHRINE HYDROCHLORIDE;
Phenylephrine Bitartrate;
PHENYLEPHRINE TANNATE;
PHENYLEPHRINE 5 MG;
Phenylephrine 0.4 MG/ML;
|
- 124. PHB
- [Encoded by human PHB Gene (Prohibitin Family), evolutionarily conserved ubiquitously expressed Prohibitin is a 272-amino acid 30 kD cytoplasmic antiproliferative protein that inhibits DNA synthesis, regulates proliferation, and may be a tumor suppressor. Prohibitin is expressed in proliferating cells. Mutations in PHB have been linked to sporadic breast cancer. (from Swiss-Prot, OMIM, and NCI) ( NCI )] (UMLS (NCI) C0084178) =Amino Acid, Peptide, or Protein; Pharmacologic Substance
| - 174. Phenylephrine Bitartrate
- [The bitartrate salt form of phenylephrine, a direct-acting sympathomimetic amine chemically related to adrenaline and ephedrine with potent vasoconstricting activity. Phenylephrine is a post-synaptic alpha-adrenergic receptor agonist that causes vasoconstriction, increases systolic/diastolic pressures, reflex bradycardia, and increases stroke output. ( NCI )] (UMLS (NCI) C0304428) =Organic Chemical; Pharmacologic Substance =PHENYLEPHRINE;
TO BE DELETED INGREDIENT PREPARATIONS |
- 125. PHB
- [This gene plays a role in the negative regulation of both apoptosis and cell proliferation. ( NCI )] (UMLS (NCI) C1335208) PHB Gene;
Prohibitin Gene =Gene or Genome | - 175. Phenylephrine/Phenylpropanolamine/Guaifenesin
- [A combination preparation containing phenylephrine, phenylpropanolamine and guaifenesin with decongestant and expectorant activities. Phenylephrine and phenylpropanolamine, direct-acting sympathicomimetic amines, activate alpha-adrenergic receptors in the nasal mucosa thereby causing vasoconstriction, reduces swelling of nasal mucous membranes and decreasing nasal and sinus congestion. Phenylpropanolamine also releases norepinephrine from its storage sites resulting in the effects already described. Guaifenesin increases respiratory tract mucus secretions and reduces the viscosity of mucus secretion by reducing adhesiveness and surface tension as well as increasing hydration of mucus, thereby increasing the efficiency of removing accumulated secretions from the upper and lower airways and making cough more productive. ( NCI )] (UMLS (NCI) C1445789) =Organic Chemical; Pharmacologic Substance
|
- 126. PHENACEMIDE
- (UMLS (NCI) C0070525) =Organic Chemical; Pharmacologic Substance ;
=[CN400] ANTICONVULSANTS;
CARBAMIDE | - 176. phenylethanol
- [An antimicrobial, antiseptic, and disinfectant that is used also as an aromatic essence and preservative in pharmaceutics and perfumery. ( MSH )] (UMLS (CSP) C0031398) =Organic Chemical; Pharmacologic Substance ;
|
- 127. phenanthrene
- [ ] (UMLS (CSP) C0031367) =Organic Chemical ;
=carbopolycyclic compound;
| - 177. phenylmethylamine
- [ ] (UMLS (CSP) C0031492) =Organic Chemical; Indicator, Reagent, or Diagnostic Aid
|
- 128. phenanthridine
- [ ] (UMLS (CSP) C0031369) =Organic Chemical ;
=nitrogenous heterocyclic compound;
=ethidium | - 178. PHENYLPROPANOLAMINE
- [An alpha- and beta-adrenergic receptor agonist with sympathomimetic activity. Phenylpropanolamine (PPA) binds to and activates alpha- and beta-adrenergic receptors in the mucosa of the respiratory tract resulting in vasoconstriction and reduction in swelling of nasal mucous membranes and reduction in tissue hyperemia, edema, and nasal congestion. This agent also stimulates the release of norepinephrine from its storage sites resulting in the effects already described. Finally, PPA indirectly stimulates beta-receptors producing tachycardia and a positive inotropic effect. ( NCI )] (UMLS (NCI) C0031495) =Organic Chemical; Pharmacologic Substance =Propanolamines;
[RE200] DECONGESTANTS, SYSTEMIC =PHENYLPROPANOLAMINE HYDROCHLORIDE;
METARAMINOL;
PHENYLPROPANOLAMINE HYDROCHLORIDE |
- 129. phenanthroline
- [ ] (UMLS (CSP) C0031370) =Organic Chemical ;
=nitrogenous heterocyclic compound;
| - 179. phenylpyruvic oligophrenia
- [ ] (UMLS (CSP) C0751434) =Disease or Syndrome
|
- 130. Phenaphthazine
- (UMLS (NCI) C0068806) =Organic Chemical; Indicator, Reagent, or Diagnostic Aid
| - 180. phenylsulfonamide
- [ ] (UMLS (CSP) C0597978) =Organic Chemical ;
|
- 131. phenazine
- [3 ring aromatic structure consisting of 2 benzene rings bridged by ortho nitrogen heteroatoms; used in dyes and larvicides; do not confuse with Phenazine, the drug trade name. ( CSP )] (UMLS (CSP) C0031375) =Organic Chemical ;
=Heterocyclic Compounds, 3-Ring;
nitrogenous heterocyclic compound =2-Phenazinamine, 3,5-dihydro-N,5-bis(4-chlorophenyl)-3-((1-methylethyl)imino)- | - 181. pheromone
- [substance secreted to the outside of the body by an individual and perceived (as by smell) by a second individual of the same species, prompting a specific behavioral reaction in the perceiver. ( CSP )] (UMLS (CSP) C0031516) =Biologically Active Substance ;
=Endocrine Gland Secretion;
|
- 132. PHENAZOPYRIDINE
- [A synthetic pyridine derivative anesthetic, Phenazopyridine is used as a local anesthetic in urinary tract disorders to relieve pain of lower urinary-tract irritation, as in cystitis, urethritis or prostatitis. Compatible with relief of pain and discomfort in antibacterial therapy, its use is limited however due to toxicity (primarily blood disorders) and potential carcinogenicity. (NCI04) ( NCI )] (UMLS (NCI) C0031379) =Organic Chemical; Pharmacologic Substance =aminopyridine;
[GU100] ANALGESICS, URINARY =2,6-Diamino-3-(phenylazo)-pyridine Hydrochloride | - 182. pheromone detector
- [ ] (UMLS (CSP) C0599626) =Body System
|
- 133. Phencarbamide
- (UMLS (NCI) C0603740) =Organic Chemical; Pharmacologic Substance
| - 183. Phetharbital
- [A short-acting barbiturate derivative without hypnotic properties, Phetharbital (N-phenylbarbital) can be used as a sedative and anticonvulsant agent due to its mechanism of enhancing GABA (Gamma Amino Butyric Acid) transmission and inhibition of synaptic excitation. Phetharbital has generally been withdrawn from clinical use. (NCI04) ( NCI )] (UMLS (NCI) C0070722) =Organic Chemical; Pharmacologic Substance ;
|
- 134. PHENDIMETRAZINE
- (UMLS (NCI) C0070549) =Organic Chemical; Pharmacologic Substance ;
=morpholine;
[GA751] CENTRALLY-ACTING APPETITE SUPPRESSANTS =(2S,3S)-3,4-Dimethyl-2-phenylmorpholine L-(+)-tartrate(1:1);
PHENDIMETRAZINE HYDROCHLORIDE;
(2S,3S)-3,4-Dimethyl-2-phenylmorpholine L-(+)-tartrate(1:1);
PHENDIMETRAZINE HYDROCHLORIDE;
PHENDIMETRAZINE 35 MG | - 184. Phial
- [A small, often stoppered glass or plastic bottle for holding medicines and chemicals. ( NCI )] (UMLS (NCI) C0184301) =Medical Device =MultiUseContainerEntityType;
|
- 135. PHENELZINE
- [monoamine oxidase inhibitor used to treat depression and phobic disorders. ( CSP )] (UMLS (NCI) C0031392) =Organic Chemical; Pharmacologic Substance ;
=[CN600] ANTIDEPRESSANTS;
hydrazine;
MAO inhibitor;
[CN602] MONOAMINE OXIDASE INHIBITOR ANTIDEPRESSANTS =2-Phenylethylhydrazine Hydrogen Sulphate | - 185. Phialophora
- [A mitosporic fungal genus. Phialophora verrucosa is a cause of chromomycosis (CHROMOBLASTOMYCOSIS). Ophiobolus is the teleomorph of Phialophora. ( MSH )] (UMLS (CSP) C0031519) =Fungus ;
|
- 136. Phenergan
- (UMLS (NCI) C0591971) =Organic Chemical; Pharmacologic Substance ;
| - 186. Philadelphia chromosome
- [An abnormality of chromosome 22 in which part of chromosome 9 is transferred to it. Bone marrow cells that contain the Philadelphia chromosome are often found in chronic myelogenous leukemia. ( NCI )] (UMLS (NCI) C0031526) =Cell Component ;
=Chromosomal Translocation;
|
- 137. PHENINDIONE
- [An indandione that has been used as an anticoagulant. Phenindione has actions similar to WARFARIN, but it is now rarely employed because of its higher incidence of severe adverse effects. (From Martindale, The Extra Pharmacopoeia, 30th ed, p234) ( MSH )] (UMLS (NCI) C0031406) =Organic Chemical; Pharmacologic Substance ;
=Indans;
=1,3-Indandione, 2-(p-methoxyphenyl)- | - 187. Philadelphia Chromosome Negative BCR-ABL1 Negative Chronic Myelogenous Leukemia
- (UMLS (NCI) C1335401) =Neoplastic Process ;
|
- 138. PHENIRAMINE
- [One of the HISTAMINE H1 ANTAGONISTS with little sedative action. It is used in treatment of hay fever, rhinitis, allergic dermatoses, and pruritus. ( MSH )] (UMLS (NCI) C0031408) =Organic Chemical; Pharmacologic Substance ;
=pyridine;
[AH400] ANTIHISTAMINES, ALKYLAMINE =BROMPHENIRAMINE;
chlorphenamine;
PHENIRAMINE MALEATE | - 188. Philadelphia Chromosome Negative BCR-ABL1 Positive Chronic Myelogenous Leukemia
- (UMLS (NCI) C1335402) =Neoplastic Process ;
|
- 139. PHENMETRAZINE
- [A sympathomimetic drug used primarily as an appetite depressant. Its actions and mechanisms are similar to DEXTROAMPHETAMINE. ( MSH )] (UMLS (NCI) C0031411) =Organic Chemical; Pharmacologic Substance ;
=morpholine;
[GA751] CENTRALLY-ACTING APPETITE SUPPRESSANTS =PHENMETRAZINE HYDROCHLORIDE | - 189. Philippine macaque
- [ ] (UMLS (CSP) C0598799) =Mammal ;
|
- 140. Phenocopy
- [An environmentally produced phenotype simulating the effect of a particular genotype. ( NCI )] (UMLS (NCI) C0678921) =Organism Attribute ;
| - 190. Philippine Peso
- [Philippine Peso, monetary currency of Philippines ( HL7V3.0 )] (UMLS (HL7) C1555434) =Quantitative Concept =Currency;
|
- 141. phenol
- [any organic compound containing one or more hydroxyl groups attached to a benzene ring. ( CSP )] (UMLS (CSP) C0031428) =Organic Chemical =Organic Chemical;
cyclic alcohol =2,6-Bis(1,1-dimethylethyl)-4-methylphenol;
catechol;
1,4 benzenediol;
nitrophenol;
phenolic amine;
Anisoles;
catechol;
Chlorophenols;
Cresols;
DIENESTROL;
Hydroquinones;
Hydroxybenzoic Acids;
Phenolphthaleins;
PROBUCOL;
PROPOFOL;
Pyrogallol;
Resorcinols;
2,4,6-tribromophenol;
Phenol | - 191. Philosophy
- [The field of study concerned with the rational investigation of questions about existence and knowledge and ethics. ( NCI )] (UMLS (NCI) C0031534) =Occupation or Discipline ;
|
- 142. Phenol
- [Hydroxybenzene; Carbolic Acid. Used as a germicidal agent and as an intermediate in chemical synthesis. Highly toxic; corrosive to the skin. ( NCI )] (UMLS (HL7) C0070570) =Organic Chemical; Pharmacologic Substance ;
=phenol;
[NT300] ANESTHETICS, MUCOSAL;
[PH000] PHARMACEUTICAL AIDS / REAGENTS;
Additive/Preservative =PHENOL,LIQUIFIED;
MENTHOL/PHENOL;
PHENOL LIQUID (ML);
Atropine 0.14 MG/ML / Edrophonium 10 MG/ML Injectable Solution;
BENZOCAINE/PHENOL/VITAMIN E/ZINC OXIDE OINT,TOP;
CAMPHOR/EUCALYPTUS/MENTHOL/PHENOL LOTION;
MASSENGILL DOUCHE POWDER,VAG;
GLYCERIN/MINERAL OIL/PHENOL LIQUID,TOP;
LANABURN OINT,TOP;
CARMEX OINT,TOP;
PHENOL 0.1 %;
PHENOL 0.25 %;
PHENOL 0.3 %;
PHENOL 0.42 %;
PHENOL 1.4 %;
PHENOL 2.8 MG/0.7ML;
PHENOL 24.2 %;
PHENOL 3 MG/ML;
PHENOL 3.3 MG/ML;
PHENOL 4.5 %;
PHENOL 0.4 %;
PHENOL 0.5 %;
PHENOL 1.45 %;
PHENOL 3 %;
PHENOL 0.72 %;
PHENOL 4.5 GM;
PHENOL 68.75 %;
PHENOL 4.7 %;
PHENOL 1 % | - 192. Phimosis
- [A condition in which the FORESKIN cannot be retracted to reveal the GLANS PENIS. It is due to tightness or narrowing of the foreskin opening. ( MSH )] (UMLS (NCI) C0031538) =Disease or Syndrome ;
=DISORDER OF PENIS NOS;
=Paraphimosis |
- 143. Phenol
- [Phenol. Urine preservative ( HL7V3.0 )] (UMLS (HL7) C1556058) =Intellectual Product =MaterialEntityAdditive;
| - 193. Phimosis/redundant prepuce
- (UMLS (ICPC) C0034919) (Phimosis/redundant prepuce; (194); Fimosis; Phimosis/slurf preputium; FIMOOSI/AHDAS ESINAHKA; Phymosis/hypertrophie du prepuce; Phimose/enge Vorhaut; (108); phimosis; Fimosi/prepuzio in eccesso; FIMOSE/OVERFLODIG FORHUD n47; Fimose/prepucio redundante; Fimosis/prepucio excesivo; FIMOS/FORTRANGNING AV FORHUDEN) Phimosis/redund prepuce =Disease or Syndrome; Anatomical Abnormality =Diagnosis/Diseases Component; Body System, Reproductive, Male
|
- 144. phenolase
- [ ] (UMLS (CSP) C0598897) =Amino Acid, Peptide, or Protein; Enzyme
| - 194. Phisohex
- (UMLS (NCI) C0308205) =Organic Chemical; Pharmacologic Substance
|
- 145. phenolate
- [ ] (UMLS (CSP) C0597206) =Organic Chemical ;
| - 195. PHLBTS DEEP VN UP EXTRM
- [ ] (UMLS (ICD9CM) C0375312) =Disease or Syndrome ;
|
- 146. phenolic amine
- [ ] (UMLS (CSP) C0597207) =Organic Chemical ;
=phenol;
phenylalkylamine =catecholamine;
octopamine;
PHENYLEPHRINE;
tyramine;
| - 196. PHLBTS SPRFC VN UP EXTRM
- [ ] (UMLS (ICD9CM) C0375311) =Disease or Syndrome ;
|
- 147. Phenolphthalein
- [An organic compound used as a laboratory reagent and pH indicator. Phenolphthalein exerts laxative effects by stimulating the intestinal mucosa and constricting smooth muscles. However, phenolphthalein is no longer used as a laxative due to the suspected carcinogenicity of this compound. ( NCI )] (UMLS (NCI) C0600489) =Organic Chemical; Pharmacologic Substance; Indicator, Reagent, or Diagnostic Aid =Phenolphthaleins;
[GA204] STIMULANT LAXATIVES;
Phenolphthalein;
Inactive Ingredient Preparations =Phenolphthalein;
PHENOLPHTHALEIN,YELLOW;
Phenolphthalein 10 MG/ML;
PHENOLPHTHALEIN 120 MG;
PHENOLPHTHALEIN 64.8 MG;
PHENOLPHTHALEIN 65 MG;
PHENOLPHTHALEIN 80 MG;
Phenolphthalein 13.4 MG/ML;
PHENOLPHTHALEIN TAB 130 MG X 2;
PHENOLPHTHALEIN,WHITE 130 MG;
PHENOLPHTHALEIN,WHITE 60 MG | - 197. PHLBTS VN NOS UP EXTRM
- [ ] (UMLS (ICD9CM) C0375313) =Disease or Syndrome ;
|
- 148. Phenomenon, Raynauds
- [Intermittent bilateral attacks of ischemia of the fingers or toes and sometimes of the ears or nose, marked by severe pallor, and often accompanied by paresthesia and pain. ( NCI )] (UMLS (NCI) C0034735) =Disease or Syndrome
| - 198. PHLDA2
- [This gene is putatively involved in the regulation of placental growth. ( NCI )] (UMLS (NCI) C1335210) PHLDA2 Gene;
Pleckstrin Homology-Like Domain, Family A, Member 2 Gene =Gene or Genome ;
|
- 149. phenone
- [ ] (UMLS (CSP) C0597208) =Organic Chemical ;
=cyclic ketone;
| - 199. phlebitis
- [Phlebitis; inflammation of a vein. ( NCI )] (UMLS (CSP) C0031542) =Disease or Syndrome ;
=angiitis;
=Postphlebitic syndrome;
thrombophlebitis;
|
- 150. Phenothiazine
- [3-ring structure of two benzene rings joined by a sulfur and a nitrogen atom; an important class of antipsychotic and other drugs which act by disrupting monoamine transmitter systems. ( CSP )] (UMLS (NCI) C0031436) =Organic Chemical; Pharmacologic Substance ;
=Heterocyclic Compounds, 3-Ring;
thiazine =2-Chloro-10-(3-(dimethylamino)propyl)phenothiazine;
1-Piperazineethanol, 4-(3-(2-(trifluoromethyl)-10H-phenothiazin-10-yl)propyl)-(9CI);
2-Chloro-10-(3-(1-methyl-4-piperazinyl)propyl)-phenothiazine;
PROMAZINE;
THIORIDAZINE;
2-Chloro-10-(3-(dimethylamino)propyl)phenothiazine;
ethopropazine;
1-Piperazineethanol, 4-(3-(2-(trifluoromethyl)-10H-phenothiazin-10-yl)propyl)-(9CI);
MESORIDAZINE;
METHOTRIMEPRAZINE;
Azul de Metileno;
4-[3-(2-Chloro-10H-phenothiazin-10-yl)propyl]-1-piperazineethanol;
PIPERACETAZINE;
2-Chloro-10-(3-(1-methyl-4-piperazinyl)propyl)-phenothiazine;
PROMAZINE;
PROMETHAZINE;
PROPIOMAZINE;
THIETHYLPERAZINE;
THIORIDAZINE;
10-(3-(4-Methyl-1-piperazinyl)propyl)-2-(trifluoromethyl)-10H-phenothiazine;
TRIFLUPROMAZINE;
TRIMEPRAZINE;
acetophenazine;
METHDILAZINE;
MORICIZINE | - 200. Phlebitis and thrombophlebitis of deep vessels of lower extremities
- [ ] (UMLS (ICD9CM) C0340711) =Disease or Syndrome
|
home
